[HTML][HTML] In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
G Almeida-Porada, A Atala, CD Porada - Molecular Therapy-Methods & …, 2016 - cell.com
Recent advances in high-throughput molecular testing have made it possible to diagnose
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
[PDF][PDF] In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
G Almeida-Porada, A Atala, CD Porada - researchgate.net
Since 1982, when Harrison et al. 1 described the first successful fetal surgery to treat
congenital hydronephrosis, tremendous progress has been made in open fetal surgery and …
congenital hydronephrosis, tremendous progress has been made in open fetal surgery and …
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
G Almeida-Porada, A Atala… - … therapy. Methods & …, 2016 - pubmed.ncbi.nlm.nih.gov
Recent advances in high-throughput molecular testing have made it possible to diagnose
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
[引用][C] In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
G Almeida-Porada, A Atala, CD Porada - Molecular Therapy-Methods & …, 2016 - cir.nii.ac.jp
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances
toward clinical application | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
toward clinical application | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
[HTML][HTML] In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
G Almeida-Porada, A Atala, CD Porada - Molecular Therapy-Methods & …, 2016 - Elsevier
Recent advances in high-throughput molecular testing have made it possible to diagnose
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
[PDF][PDF] In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
G Almeida-Porada, A Atala, CD Porada - scienceopen.com
Since 1982, when Harrison et al. 1 described the first successful fetal surgery to treat
congenital hydronephrosis, tremendous progress has been made in open fetal surgery and …
congenital hydronephrosis, tremendous progress has been made in open fetal surgery and …
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application.
G Almeida-Porada, A Atala… - … therapy. Methods & …, 2016 - europepmc.org
Recent advances in high-throughput molecular testing have made it possible to diagnose
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
[HTML][HTML] In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
G Almeida-Porada, A Atala… - … Therapy. Methods & …, 2016 - ncbi.nlm.nih.gov
Recent advances in high-throughput molecular testing have made it possible to diagnose
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
G Almeida-Porada, A Atala… - … Therapy. Methods & …, 2016 - search.proquest.com
Recent advances in high-throughput molecular testing have made it possible to diagnose
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
G Almeida-porada, A Atala… - … Therapy. Methods & …, 2016 - search.proquest.com
Recent advances in high-throughput molecular testing have made it possible to diagnose
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …
most genetic disorders relatively early in gestation with minimal risk to the fetus. These …